High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids

BACKGROUND: A high strength of beclomethasone/formoterol fumarate (BDP/FF) in a pressurised metered dose inhaler (pMDI), which contains extrafine BDP (200 μg/actuation) and FF (6 μg/actuation) has been developed to treat those asthmatics who are not adequately controlled on previous treatments. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Paggiaro, Pierluigi, Corradi, Massimo, Latorre, Manuela, Raptis, Helene, Muraro, Annamaria, Gessner, Christian, Siergiejko, Zenon, Scuri, Mario, Petruzzelli, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148913/
https://www.ncbi.nlm.nih.gov/pubmed/27938358
http://dx.doi.org/10.1186/s12890-016-0335-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148913/
https://www.ncbi.nlm.nih.gov/pubmed/27938358
http://dx.doi.org/10.1186/s12890-016-0335-9

Ejemplares similares